The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
- PMID: 17165132
- DOI: 10.1007/s10555-006-9019-x
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
Abstract
Tumor cells are known to adapt to and utilize existing physiological mechanisms to promote survival and metastasis. The role of the microenvironment in the establishment of a metastatic lesion has become increasingly important as several factors secreted by stromal cells regulate metastatic pattern in a variety of tumor types. Tumor cells interact with osteoblasts, osteoclasts and bone matrix to form a vicious cycle that is essential for successful metastases. Here we review the current concepts regarding the role of an important chemokine/chemokine receptor (SDF-1 or CXCL12/CXCR4) pathway in tumor development and metastasis. CXCL12 secretion by stromal cells is known to attract cancer cells via stimulation of the CXCR4 receptor that is up regulated by tumor cells. CXCL12/CXCR4 activation regulates the pattern of metastatic spread with organs expressing high levels of CXCL12 developing secondary tumors (i.e., the bone marrow compartment). CXCL12 has a wide range of effects in regards to tumor development but the primary role of CXCL12 appears to be the mobilization of hematopoietic stem cells and the establishment of the cancer stem-like cell niche where high levels of CXCL12 recruit a highly tumorigenic population of tumor cells and promotes cell survival, proliferation, angiogenesis, and metastasis.
Similar articles
-
Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.Stem Cells. 2005 Aug;23(7):879-94. doi: 10.1634/stemcells.2004-0342. Epub 2005 May 11. Stem Cells. 2005. PMID: 15888687 Review.
-
Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):490-7. Clin Cancer Res. 2005. PMID: 15701832
-
Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.Bone. 2005 May;36(5):840-53. doi: 10.1016/j.bone.2005.01.021. Epub 2005 Mar 24. Bone. 2005. PMID: 15794931
-
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.Biomed Pharmacother. 2006 Jul;60(6):273-6. doi: 10.1016/j.biopha.2006.06.004. Epub 2006 Jun 28. Biomed Pharmacother. 2006. PMID: 16828253 Review.
-
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.J Bone Miner Res. 2005 Feb;20(2):318-29. doi: 10.1359/JBMR.041109. Epub 2004 Nov 16. J Bone Miner Res. 2005. PMID: 15647826
Cited by
-
Tumor dormancy in bone.Cancer Rep (Hoboken). 2020 Feb;3(1):e1156. doi: 10.1002/cnr2.1156. Epub 2019 Jan 29. Cancer Rep (Hoboken). 2020. PMID: 32632400 Free PMC article. Review.
-
Molecular mechanisms and clinical management of cancer bone metastasis.Bone Res. 2020 Jul 29;8(1):30. doi: 10.1038/s41413-020-00105-1. eCollection 2020. Bone Res. 2020. PMID: 32793401 Free PMC article. Review.
-
Progression of prostate carcinoma is promoted by adipose stromal cell-secreted CXCL12 signaling in prostate epithelium.NPJ Precis Oncol. 2021 Mar 22;5(1):26. doi: 10.1038/s41698-021-00160-9. NPJ Precis Oncol. 2021. PMID: 33753872 Free PMC article.
-
Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion.Cell Adh Migr. 2009 Oct-Dec;3(4):328-33. doi: 10.4161/cam.3.4.9211. Epub 2009 Oct 5. Cell Adh Migr. 2009. PMID: 19550136 Free PMC article. Review.
-
A short account of metastatic bone disease.Cancer Cell Int. 2011 Jul 27;11:24. doi: 10.1186/1475-2867-11-24. Cancer Cell Int. 2011. PMID: 21794164 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical